ArticleTherapeutic advances in rare disease

Safety of home administration of cipaglucosidase alfa plus miglustat in late-onset Pompe disease: results from multiple clinical trials.

Henning Andersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.